Pharvaris NV (PHVS)
38.66
+0.92
(+2.44%)
USD |
NASDAQ |
Sep 10, 11:45
Pharvaris 1 Year Total Returns (Daily) : 57.64% for Sept. 9, 2026
1 Year Total Returns (Daily) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical 1 Year Total Returns (Daily) Data
| Date | Value |
|---|---|
| September 09, 2026 | 57.64% |
| September 08, 2026 | 73.34% |
| September 04, 2026 | 60.37% |
| September 03, 2026 | 62.76% |
| September 02, 2026 | 56.31% |
| September 01, 2026 | 61.34% |
| August 31, 2026 | 59.86% |
| August 28, 2026 | 54.64% |
| August 27, 2026 | 55.59% |
| August 26, 2026 | 54.17% |
| August 25, 2026 | 57.42% |
| August 24, 2026 | 61.38% |
| August 21, 2026 | 55.33% |
| August 20, 2026 | 58.22% |
| August 19, 2026 | 55.93% |
| August 18, 2026 | 62.91% |
| August 17, 2026 | 58.39% |
| August 14, 2026 | 52.85% |
| August 13, 2026 | 58.84% |
| August 12, 2026 | 72.88% |
| August 11, 2026 | 65.16% |
| August 10, 2026 | 73.16% |
| August 07, 2026 | 71.80% |
| August 06, 2026 | 62.27% |
| August 05, 2026 | 59.14% |
| Date | Value |
|---|---|
| August 04, 2026 | 59.50% |
| August 03, 2026 | 61.25% |
| July 31, 2026 | 64.08% |
| July 30, 2026 | 71.20% |
| July 29, 2026 | 66.34% |
| July 28, 2026 | 68.22% |
| July 27, 2026 | 64.74% |
| July 24, 2026 | 70.42% |
| July 23, 2026 | 59.60% |
| July 22, 2026 | 48.62% |
| July 21, 2026 | 44.50% |
| July 20, 2026 | 44.33% |
| July 17, 2026 | 47.24% |
| July 16, 2026 | 46.35% |
| July 15, 2026 | 52.94% |
| July 14, 2026 | 44.62% |
| July 13, 2026 | 39.61% |
| July 10, 2026 | 76.85% |
| July 09, 2026 | 94.38% |
| July 08, 2026 | 99.81% |
| July 07, 2026 | 92.17% |
| July 06, 2026 | 78.60% |
| July 02, 2026 | 90.01% |
| July 01, 2026 | 96.81% |
| June 30, 2026 | 96.48% |
Total Return Definition
The Total return is the change in price over a specific period of time that includes dividends and distributions paid.
1 Year Total Returns (Daily) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
1 Year Total Returns (Daily) Benchmarks
| Novartis AG | 10.63% |
| BioAge Labs, Inc. | 84.14% |
| AstraZeneca PLC | -1.72% |
| ANI Pharmaceuticals, Inc. | -28.19% |
| Corcept Therapeutics, Inc. | 61.30% |